Mark N. Boldrin
Impact in
- Pharmacology top 0.5%
- Pharmacology and Obesity Treatment
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
Papers in
- Pharmacology 11
- Pharmacology and Obesity Treatment 11
- Pharmacogenetics and Drug Metabolism 2
-
- Diabetes Treatment and Management 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Co-authors
- Lars Sjöström (4 shared papers)Jonathan B. Hauptman (7 shared papers)Jarl Torgerson (1 shared paper)Aila Rissanen (2 shared papers)Hans P. F. Koppeschaar (2 shared papers)Michel Krempf (2 shared papers)Alain Golay (2 shared papers)Teis Andersen (1 shared paper)
- Journals
- Diabetes Care (4 papers)The American Journal of Cardiology (2 papers)Diabetologia (2 papers)Diabetic Medicine (2 papers)Diabetes Obesity and Metabolism (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark N. Boldrin
24 papers receiving 3.5k citations
Mark N. Boldrin's Hit Papers
Peers
Comparison fields: 5 of 92
- Pharmacology 1.7k
- Endocrinology, Diabetes and Metabolism 1.1k
- Pharmacy 106
- Endocrine and Autonomic Systems 114
- Public Health, Environmental and Occupational Health 524
Countries citing papers authored by Mark N. Boldrin
This map shows the geographic impact of Mark N. Boldrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Boldrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Boldrin more than expected).
Fields of papers citing papers by Mark N. Boldrin
This network shows the impact of papers produced by Mark N. Boldrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Boldrin. The network helps show where Mark N. Boldrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark N. Boldrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study Hit paper breakdown → | 2004 | 1461 |
| 2 | Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients Hit paper breakdown → | 1998 | 953 |
| 3 | 2005 | 474 | |
| 4 | 2000 | 277 | |
| 5 | 2012 | 102 | |
| 6 | 2009 | 99 | |
| 7 | 2001 | 78 | |
| 8 | 1999 | 70 | |
| 9 | 2001 | 62 | |
| 10 | [Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients]. | 2000 | 60 |
| 11 | 2004 | 48 | |
| 12 | 2012 | 44 | |
| 13 | 2003 | 38 | |
| 14 | 2006 | 37 | |
| 15 | 2010 | 37 | |
| 16 | 2012 | 32 | |
| 17 | 2012 | 26 | |
| 18 | 2012 | 19 | |
| 19 | 2005 | 12 | |
| 20 | 2013 | 8 |
About Mark N. Boldrin
Mark N. Boldrin is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Pharmacology, Rheumatology and Clinical Psychology, having authored 24 papers that have together received 4k indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (11 papers), Diabetes Treatment and Management (10 papers), Pharmacogenetics and Drug Metabolism (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Folate and B Vitamins Research (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper), Adipose Tissue and Metabolism (1 paper) and Eating Disorders and Behaviors (1 paper). The work is most often cited by research in Pharmacology (1.7k citations), Endocrinology, Diabetes and Metabolism (1.1k citations), Pharmacy (106 citations), Endocrine and Autonomic Systems (114 citations) and Public Health, Environmental and Occupational Health (524 citations). Mark N. Boldrin has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Lars Sjöström, Jonathan B. Hauptman, Jarl Torgerson, Aila Rissanen, Hans P. F. Koppeschaar, Michel Krempf, Alain Golay, Teis Andersen, Sarah E. Hampl and Jean‐Pierre Chanoine. Their work appears in journals such as Diabetes Care, The American Journal of Cardiology, Diabetologia, Diabetic Medicine and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.